Noriyuki Yoshida

Prognostic significance of tumor/stromal caveolin‐1 expression in breast cancer patients

T. Inamoto, T. Wakasa, M. Toi, 2011, Cancer science.

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

H. Sasano, N. Masuda, H. Yamashita, 2013, Breast Cancer Research and Treatment.

Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1

T. Ohkusa, M. Saruta, H. Sugiyama, 2019, Oncology.

Abstract P1-14-02: Preoperative docetaxel (T) with or without capecitabine (X) following epirubicin, 5-fluorouracil and cyclophosphamide (FEC) in patients with operable breast cancer (OOTR N003): Results of comparative study and predictive marker analysis

H. Iwata, H. Sasano, N. Masuda, 2012 .